MALARIA FALCIPARUM

This study is testing two new malaria vaccine combinations in young children in Burkina Faso, where malaria is common. It will involve 360 healthy children aged 5 to 36 months to see if the vaccines are safe and how well they prevent malaria over six months. The goal is to find a…

This early-stage study is testing whether giving multiple increasing doses of the R21 malaria vaccine is safe and triggers a good immune response. It involves 36 healthy UK adults who have never had malaria. Researchers will compare this new multi-dose schedule against the standa…

This study is testing a new malaria vaccine called SUM-101 in young children and infants for the first time. It aims to find out if the vaccine is safe, what side effects it might cause, and if it produces a good immune response against malaria. The study involves 69 healthy chil…

This is a first-in-human safety study of a new malaria vaccine. It will be given to 75 healthy adults and children in Burkina Faso who have been exposed to malaria before. The vaccine uses a weakened malaria parasite that gets trapped and destroyed in the liver, aiming to safely …

This study is testing a new strategy to reduce malaria transmission in Senegal by targeting people who carry the malaria parasite without showing symptoms. It involves giving preventive malaria drugs to everyone in selected communities twice a year, combined with extra testing an…

This study is testing whether giving malaria prevention medicine to school children every six weeks during the rainy season can protect the children themselves and also reduce malaria infections in younger children living in their households. It involves 1,000 students in rural M…